ストックスクリーナーアプリを入手
4.05
0.00%
0.00
前日終値:
$4.05
開ける：
$4.05
24時間の取引高:
85,361
Relative Volume:
0.44
時価総額：
$14.49M
収益：
$36.12M
当期純損益:
$-232.49M
株価収益率:
-0.2278
EPS:
-17.78
ネットキャッシュフロー:
$-126.87M
1週間 パフォーマンス:
-7.95%
1か月 パフォーマンス:
+16.71%
6か月 パフォーマンス:
-79.29%
1年 パフォーマンス:
-91.73%
1日の値動き範囲:
$4.00
$4.2271
1週間の範囲:
$3.96
$5.22
52週間の値動き範囲:
$2.68
$72.60
Bionano Genomics Inc Stock (BNGO) Company Profile
名前
Bionano Genomics Inc
セクター
電話
(858) 888-7600
住所
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
BNGO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
4.05 | 14.49M | 36.12M | -232.49M | -126.87M | -17.78 |
|
ISRG
Intuitive Surgical Inc
|
482.74 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
198.71 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.54 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
212.91 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.51 | 15.75B | 3.90B | 392.30M | 288.10M | 1.95 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-15 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2024-09-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-12-12 | 再開されました | BTIG Research | Buy |
| 2022-07-18 | 再開されました | Oppenheimer | Outperform |
| 2021-06-16 | 開始されました | BTIG Research | Buy |
| 2020-09-24 | 開始されました | Ladenburg Thalmann | Buy |
| 2020-04-08 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Bionano Genomics Inc (BNGO) 最新ニュース
Bionano Genomics (BNGO) Projects Stable Revenue Growth for 2025 - GuruFocus
Bionano Genomics (BNGO) Sees Revenue Upgrade Despite Lower Price Target - GuruFocus
Bionano Genomics (BNGO) Faces Revenue Growth, Missed EPS Targets - GuruFocus
Bionano Genomics (BNGO) Advances Multiple Myeloma Analysis - GuruFocus
Bionano Genomics (BNGO) Reports Q4 2024 Earnings: Revenue Decline but Margin Improvement - GuruFocus
HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BMV:BNGO) with Buy Recommendation - Nasdaq
HC Wainwright & Co. Initiates Coverage of Bionano Genomics (LSE:0A4K) with Buy Recommendation - Nasdaq
HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BNGO) with Buy Recommendation - Nasdaq
HC Wainwright Initiates Bionano Genomics With Buy Rating, $10 Price Target - marketscreener.com
Richardson Electronics Q3 2025 Earnings Call Transcript - MarketBeat
Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM - The Manila Times
Breakthrough: French Study Reveals Game-Changing Multiple Myeloma Detection Method - Stock Titan
(BNGO) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Revenues Working Against Bionano Genomics, Inc.'s (NASDAQ:BNGO) Share Price Following 26% Dive - simplywall.st
Bionano Genomics Inc Reports Q4 Revenue of $8.2 Million, Surpassing Estimates - GuruFocus
Analysts Are Upgrading Bionano Genomics, Inc. (NASDAQ:BNGO) After Its Latest Results - Yahoo Finance
Bionano Genomics Q4 Earnings Call: Mixed Sentiments and Strategic Shifts - TipRanks
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2024 Earnings Call Transcript - Insider Monkey
Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... - Yahoo Finance
Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... By GuruFocus - Investing.com Canada
Bionano Genomics Reports 2024 Financial Results - TipRanks
Bionano Genomics outlines 2025 revenue guidance of $29M-$32M with strategic focus on utilization - MSN
Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript - Yahoo Finance
Bionano Genomics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Bionano Genomics Q4 2024 sees revenue drop By Investing.com - Investing.com South Africa
Earnings call transcript: Bionano Genomics Q4 2024 sees revenue drop - Investing.com
Bionano Genomics, Inc. SEC 10-K Report - TradingView
Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025 - The Manila Times
Bionano Genomics Reports Q4 and Full-Year 2024 Results - TradingView
Stock Market Correction: 2 Warren Buffett Stocks to Buy Hand Over Fist - The Globe and Mail
Bionano Genomics Inc expected to post a loss of $6.00 a shareEarnings Preview - TradingView
SoFi Stock Is Down 23% YTD. Should You Buy the Dip or Stay Away? - The Globe and Mail
What's Next: Bionano Genomics's Earnings Preview - Benzinga
Q4 Earnings Outperformers: Fastenal (NASDAQ:FAST) And The Rest Of The Maintenance and Repair Distributors Stocks - The Globe and Mail
Hakluyt appoints Ronald Sugar to its International Advisory Board - The Globe and Mail
BNGO stock touches 52-week low at $3.15 amid market challenges By Investing.com - Investing.com South Africa
BNGO stock touches 52-week low at $3.15 amid market challenges - Investing.com Australia
LYFT Stock Gains as Activist Investor Engine Capital Builds Stake - The Globe and Mail
Bionano Genomics and Greenwood Genetic Center Publish Study Using Optical Genome Mapping to Advance Understanding of Neural Tube Defects - Nasdaq
Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect - The Manila Times
Major Discovery: New Genes Linked to Birth Defects Found Using Advanced DNA Mapping - StockTitan
3 Services Stocks Skating on Thin Ice - The Globe and Mail
BNGO stock touches 52-week low at $3.28 amid market challenges - Investing.com Australia
BNGO stock touches 52-week low at $3.28 amid market challenges By Investing.com - Investing.com South Africa
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting - The Manila Times
Leading Experts Validate Bionano's Genome Mapping Technology at Major Medical Conference - StockTitan
(BNGO) Technical Data - Stock Traders Daily
Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025 - The Manila Times
Bionano Genomics Inc (BNGO) 財務データ
収益
当期純利益
現金流量
EPS
0.90%
3.46%
大文字化:
|
ボリューム (24 時間):